Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors.
Sujha SubramanianRobai GakungaJoseph KibachioGladwell GathechaPatrick EdwardsElijah OgolaGerald YongaNaftali BusakhalaEsther MunyoroJeremiah ChakayaNancy NgugiNyawira MwangiDaniel Von RegeLili-Marie WangariDavid WataRobert MakoriJulius MwangiWalter Mwandanull nullPublished in: PloS one (2018)
There is substantial variation in patient costs between the public and private sectors. Most NCD diagnosis and treatment costs, even in the public sector, represent a substantial economic burden that can result in catastrophic expenditures.